PACTR201807337809744
Not yet recruiting
未知
Effect of transjugular intrahepatic portosystemic shunt insertion in hepatic patients on the haemodynamics
ational Liver Institute0 sites40 target enrollmentJuly 30, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Liver Institute
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patients scheduled for elective TIPS procedure with stable haemodynamic condition and acceptable echocardiography.
Exclusion Criteria
- •Cardiac co\-morbidity.
- •Severe coagulation disorder.
- •Renal failure.
- •Neoplastic disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Influence of the transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients on sarcopeniaMuscle wasting and atrophy, not elsewhere classified, multiple sitesM62.59K74.6Other and unspecified cirrhosis of liverDRKS00024507niversitätsklinikum Freiburg100
Withdrawn
Not Applicable
The effects of Transjugular Intrahepatic Portosystemic Shunt placement on von Willebrand factor levels in plasma of patients with cirrhosis and portal hypertension.NL-OMON38711niversitair Medisch Centrum Groningen16
Completed
Not Applicable
The impact of trans-jugular intrahepatic portosystemic shunts on muscle mass in chronic liver disease.cirrhosisportal hypertensionsarcopeniaTrans-jugular intrahepatic portosystemic shuntOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disordersACTRN12619000081112Department of Gastroenterology and Hepatology, Austin Health14
Completed
Not Applicable
Covered transjugular intrahepatic portosystemic stent shunt versus optimised medical treatment for the secondary prevention of variceal bleeding in cirrhosisISRCTN16334693Individual sponsor (Germany)186
Active, not recruiting
Not Applicable
Covered Transjugular Intrahepatic Portosystemic Stent Shunt versus Optimized medical Treatment for the Secondary Prevention of Variceal Bleeding in Cirrhosisliver cirrhosisesophageal (variceal) bleedingEUCTR2005-003557-27-DEDean of the Medical Faculty (University of Bonn)